Professor George Hanna, head of the Department of Surgery and Cancer at Imperial College London – who is leading the project, said: “If our findings from the initial phase of the breath test study can be validated in a population of patients with an unknown diagnosis, it has huge potential to influence clinical practice and pancreatic cancer referral pathways.
